KOPIN CORP
Business
Kopin Corporation designs and manufactures microdisplay technologies (AMLCDs, LCOS, OLED, and MicroLED) and application-specific optical solutions (ASOS) for defense, industrial, medical, and consumer markets. Products include standalone displays, display modules, and integrated headsets for thermal weapon sights, pilot helmets, training systems, industrial field-service headsets, surgical headsets, and emerging AR/VR applications. The company operates through market-focused and technology-focused groups across Westborough Massachusetts, Dalgety Bay Scotland, and Reston Virginia, with manufacturing partnerships in Taiwan, South Korea, and Europe.
Summary from 10-K filed 2026-04-13
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Total revenues | 39 | 50 | 40 | 47 | 46 | |
| Cost of product revenues | 28 | 36 | 25 | 33 | 25 | |
| Research and development-Funded | 3 | 4 | — | — | — | |
| Research and development Internal | 7 | 6 | 4 | 8 | 6 | |
| Selling, general and administrative | 16 | 23 | 22 | 18 | 18 | |
| Litigation damages | −5 | 25 | — | — | — | |
| Total operating expenses | 49 | 93 | 58 | 69 | 59 | |
| Loss from operations | −10 | −43 | −17 | −22 | −14 | |
| Interest income | 1 | 817,180 | 829,602 | 76,877 | 31,142 | |
| Other income, net | 154,194 | 19,989 | 245,234 | 154,357 | 265,509 | |
| Foreign currency transaction gains | 286,268 | 175,909 | −162,204 | −323,286 | 139,014 | |
| Gain on deconsolidation of subsidiary | 11 | — | — | — | — | |
| Gain (loss) on investments | 1,396 | −2 | −3 | 3 | — | |
| Total non-operating income (expense) | 13 | −599,070 | −2 | 3 | 435,665 | |
| Income (loss) before provision for income taxes | 3 | −44 | −20 | −19 | −13 | |
| Provision for income taxes | −208,000 | −170,000 | −156,000 | −144,000 | −129,000 | |
| Net income (loss) | 3 | −44 | −20 | −19 | −13 | |
| Dividends and deemed dividends on Series A convertible preferred stock | −57,167 | — | — | — | — | |
| Net income (loss) attributable to common stockholders | 3 | −44 | — | — | — | |
| Basic (per share) | 0.01 | −0.33 | −0.18 | −0.21 | −0.15 | |
| Diluted (per share) | 0.01 | −0.33 | −0.18 | −0.21 | −0.15 | |
| Basic (shares) | 171 | 133 | 109 | 91 | 89 | |
| Diluted (shares) | 175 | 133 | 109 | 91 | 89 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 36 | 14 | — | — | — | |
| Restricted cash and cash equivalents | 25 | 1 | 500,000 | — | — | |
| Marketable securities, at fair value | — | 21 | 12 | 4 | 3 | |
| Accounts receivable, net of allowance of $19,000 and $1,075,000 in 2025 and 2024, respectively | 11 | 12 | 10 | 7 | 12 | |
| Contract assets | 6 | 7 | 3 | 4 | 2 | |
| Inventory | 6 | 6 | 8 | 6 | 7 | |
| Other receivable, at fair value | 5 | — | — | — | — | |
| Prepaid expenses and other current assets | 3 | 1 | 1 | 1 | 2 | |
| Total current assets | 92 | 63 | 40 | 31 | 52 | |
| Property, plant and equipment, net | 3 | 2 | 2 | 2 | 2 | |
| Operating lease right-of-use assets | 1 | 2 | 3 | 3 | 4 | |
| Other assets | 123,822 | 123,822 | 124,925 | 170,132 | 170,932 | |
| Equity method investment, at fair value | 9 | — | — | — | — | |
| Equity investments | 3 | 4 | — | — | — | |
| Total assets | 108 | 71 | 49 | 44 | 63 | |
| Accounts payable | 5 | 6 | 5 | 5 | 5 | |
| Accrued payroll and expenses | 2 | 2 | 2 | 3 | 2 | |
| Accrued warranty | 1 | 3 | 2 | 2 | 517,000 | |
| Contract liabilities | 1 | 87,752 | 900,000 | 930,500 | 4 | |
| Deferred grant income | 3 | — | — | — | — | |
| Operating lease liabilities | 648,469 | 639,642 | 651,503 | 786,928 | 701,204 | |
| Accrued post-retirement benefits | 40,000 | 40,000 | — | — | — | |
| Other accrued liabilities | 422,440 | 685,946 | 2 | 1 | 1 | |
| Accrued legal expenses | 185,475 | 6 | 2 | — | — | |
| Deferred tax liabilities | 422,458 | 414,118 | 470,884 | 482,739 | — | |
| Accrued litigation damages | 20 | 25 | — | — | — | |
| Total current liabilities | 34 | 44 | 16 | 14 | 18 | |
| Noncurrent contract liabilities and asset retirement obligations | 3,675 | 358,292 | 278,112 | 248,284 | 288,634 | |
| Operating lease liabilities, net of current portion | 831,507 | 1 | 2 | 3 | 3 | |
| Accrued post-retirement benefits, net of current portion | 190,696 | 230,646 | — | — | — | |
| Other long-term liabilities, net of current portion | 2 | 1 | 1 | 1 | 1 | |
| Total liabilities | 37 | 47 | 20 | 20 | 23 | |
| Commitments and contingencies (Note 13) and Litigation (Note 14) | — | — | — | — | — | |
| Preferred stock, par value $.01 per share: authorized, 3,000 shares; no shares issued and outstanding as of 2025 and 2024 | — | — | — | — | — | |
| Common stock, par value $0.01; 275,000,000 shares authorized, 183,015,207 issued, and 176,903,857 outstanding at December 27, 2025; 200,000,000 shares authorized, 161,264,507 issued, and 156,118,014 outstanding at December 28, 2024 | 2 | 2 | 1 | 929,540 | 900,691 | |
| Additional paid-in capital | 463 | 422 | 385 | 361 | 357 | |
| Treasury stock 771,500 shares in 2025 and 312,882 shares in 2024, at cost) | −1 | −370,012 | −103,127 | −103,127 | −366,110 | |
| Accumulated other comprehensive income | — | 2 | 1 | 1 | 1 | |
| Accumulated deficit | −399 | −402 | −358 | −338 | −319 | |
| Total stockholders equity | 64 | 23 | 30 | 24 | 40 | |
| Total liabilities, redeemable convertible preferred stock, and stockholders equity | 108 | 71 | 49 | 44 | 63 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net income (loss) | 3 | −44 | — | — | — | |
| Depreciation and amortization | 829,554 | 636,580 | 608,222 | 722,024 | 668,691 | |
| Stock-based compensation | 3 | 3 | 4 | 1 | 4 | |
| Non-cash (gain) loss on equity investments | −161,406 | 2 | — | — | — | |
| Gain on sale of equity investment | −300,000 | — | 3 | −3 | −300,000 | |
| Gain on deconsolidation of subsidiary | −11 | — | — | — | — | |
| Income taxes | 208,912 | 170,642 | — | 143,345 | 128,279 | |
| Foreign currency gains | −326,085 | −207,926 | 91,791 | 449,443 | −186,942 | |
| Loss on disposal of property and equipment | 88,236 | 59,151 | 46,231 | 317,032 | 99,228 | |
| Provision for credit losses | 10,000 | 105,842 | 709,721 | 162,638 | — | |
| Noncash provision for excess inventory | 968,116 | 2 | 1 | 2 | — | |
| Accrued litigation damages | −5 | 25 | — | — | — | |
| Accounts receivable | 896,158 | −2 | −5 | 7 | −3 | |
| Contract assets | 942,197 | −4 | 821,094 | −2 | 1 | |
| Inventory | −1 | −922,589 | −2 | −2 | −3 | |
| Prepaid expenses and other current assets | −2 | 53,610 | −202,504 | 908,156 | −691,573 | |
| Other assets | −240,646 | — | — | — | — | |
| Accounts payable and accrued expenses | −7 | 4 | 2 | −4 | 143,379 | |
| Accrued warranty | −1 | 396,451 | — | — | — | |
| Contract liabilities | 4 | −845,041 | 3,568 | −3 | 3 | |
| Net cash used in operating activities | −16 | −14 | −15 | −18 | −11 | |
| Proceeds from sale of marketable securities | 36 | 10 | 10 | 2 | 1 | |
| Proceeds from sale of equity investment | 300,000 | — | — | — | — | |
| Other assets | — | −45 | 62,694 | 20,909 | −12,822 | |
| Capital expenditures | −1 | −815,299 | −949,487 | −832,712 | −1 | |
| Deconsolidation of subsidiary cash | −419,383 | — | — | — | — | |
| Payments to equity method investee | −2 | — | — | — | — | |
| Purchases of marketable securities | −15 | −19 | −18 | −4 | — | |
| Net cash used in investing activities | 18 | −10 | −8 | −3 | 53,675 | |
| Issuance of common stock and pre-funded warrants, net of costs | 38 | 34 | 21 | 2 | — | |
| Issuance of preferred stock, net of costs | 7 | — | — | — | — | |
| Settlements of restricted stock for tax withholding obligations | −1 | −266,885 | — | −198,740 | −602,080 | |
| Net cash provided by financing activities | 44 | 34 | 21 | 3 | 20 | |
| Effect of exchange rate changes on cash | 3,993 | −952 | 14,463 | −190,585 | −80,124 | |
| Net change in cash, cash equivalents and restricted cash | 46 | 9 | −2 | −19 | 10 | |
| Construction in progress included in accrued expenses | 3,600 | 17,000 | — | — | — | |
| Right-of-use asset obtained in exchange for lease liability | — | 217,046 | — | — | — | |
| Interest paid, net of amounts capitalized | — | — | — | — | — | |
| Cash paid for income taxes | — | — | — | — | — | |
| Accrued dividends | 28,000 | — | — | — | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is KOPIN CORP's CIK number?
KOPIN CORP's SEC CIK number is 0000771266 (771266). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find KOPIN CORP's SEC filings?
All of KOPIN CORP's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did KOPIN CORP last report earnings?
KOPIN CORP (KOPN) most recently filed an earnings 8-K with the SEC on May 12, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001493152-26-022462). This is KOPIN CORP's most recent earnings filing of record — not a forecast of its next earnings date.
What is KOPIN CORP's most recent earnings 8-K?
KOPIN CORP's latest earnings 8-K (Item 2.02) was filed May 12, 2026 under accession 0001493152-26-022462. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View KOPIN CORP's latest earnings 8-K →
Look up any company's CIK number →